Structure Therapeutics Inc. American Depositary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
GPCR Company Description
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
GPCR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view GPCR Smart Score
Score Breakdown
GPCR Company Description
Show More
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of GPCR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by GPCR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of GPCR in WallStreetBets Daily Discussion
GPCR News
Recent insights relating to GPCR
CNBC Recommendations
Recent picks made for GPCR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in GPCR
Corporate Flights
Flights by private jets registered to GPCR
Our Analysis